Spire Healthcare Group PLC Transaction in Own Shares

RNS Number : 8971K

Spire Healthcare Group PLC

05 November 2024

 

5 November 2024

Spire Healthcare Group plc

Transaction in own shares

Spire Healthcare Group plc (the "Company") announces that, in accordance with the terms of its share buyback programme announced on 31 October 2024 (the "Share Buyback Programme") and the authority granted by its shareholders at the Company's 2024 Annual General Meeting held on 9 May 2024, it has purchased the following number of its ordinary shares of 1 pence each ("Shares") on the London Stock Exchange through Numis Securities Limited ("Deutsche Numis"):

Date of purchase:	4 November 2024
Number of Shares purchased:	50,000
Highest price paid per Share (GBp):	221.50
Lowest price paid per Share (GBp):	218.50
Volume weighted average price paid per Share (GBp):	220.5045
Broker:	Deutsche Numis
Trading venue:	London Stock Exchange

           

The purchased Shares will be cancelled.

Following the purchase of these Shares, the remaining number of Shares in issue will be 404,038,352. The Company does not hold any Shares in treasury. Therefore, the total number of voting rights in the Company is 404,038,352. This figure may be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Deutsche Numis as part of the Share Buyback Programme:

 

Date of purchase	Number of ordinary shares purchased	Transaction price (GBp share)	Time of transaction (UK Time)	Transaction reference number	Trading venue
4 November 2024	1586	220.50	08:36:51	00072200832TRLO0	XLON
4 November 2024	771	220.50	08:36:51	00072200831TRLO0	XLON
4 November 2024	2016	221.00	08:47:13	00072201138TRLO0	XLON
4 November 2024	1646	221.00	08:47:13	00072201139TRLO0	XLON
4 November 2024	40	221.00	08:47:13	00072201140TRLO0	XLON
4 November 2024	264	221.00	08:47:13	00072201141TRLO0	XLON
4 November 2024	472	221.00	09:01:17	00072201508TRLO0	XLON
4 November 2024	25000	220.75	09:01:37	00072201527TRLO0	XLON
4 November 2024	434	220.00	10:44:56	00072204405TRLO0	XLON
4 November 2024	127	220.00	10:44:56	00072204406TRLO0	XLON
4 November 2024	127	220.00	10:44:56	00072204407TRLO0	XLON
4 November 2024	1556	220.00	10:44:56	00072204408TRLO0	XLON
4 November 2024	222	221.50	10:54:07	00072204669TRLO0	XLON
4 November 2024	850	221.50	10:54:07	00072204670TRLO0	XLON
4 November 2024	973	221.50	10:55:47	00072204731TRLO0	XLON
4 November 2024	923	221.50	11:05:10	00072205036TRLO0	XLON
4 November 2024	343	221.50	11:05:10	00072205037TRLO0	XLON
4 November 2024	320	221.50	11:05:10	00072205038TRLO0	XLON
4 November 2024	2360	221.50	11:10:43	00072205174TRLO0	XLON
4 November 2024	87	220.00	13:11:18	00072207817TRLO0	XLON
4 November 2024	1875	220.00	13:11:18	00072207818TRLO0	XLON
4 November 2024	2259	219.00	14:20:54	00072210063TRLO0	XLON
4 November 2024	1099	219.00	15:20:54	00072212396TRLO0	XLON
4 November 2024	144	219.00	15:20:54	00072212397TRLO0	XLON
4 November 2024	200	219.00	15:20:54	00072212398TRLO0	XLON
4 November 2024	1017	219.00	15:32:47	00072212761TRLO0	XLON
4 November 2024	62	219.00	15:32:47	00072212762TRLO0	XLON
4 November 2024	1223	219.00	15:53:28	00072213471TRLO0	XLON
4 November 2024	135	219.00	15:53:28	00072213472TRLO0	XLON
4 November 2024	1371	219.00	16:02:28	00072213866TRLO0	XLON
4 November 2024	140	219.00	16:02:28	00072213867TRLO0	XLON
4 November 2024	117	219.00	16:02:28	00072213868TRLO0	XLON
4 November 2024	71	218.50	16:05:01	00072213977TRLO0	XLON
4 November 2024	170	218.50	16:05:01	00072213978TRLO0	XLON

 

This announcement will also be available on the Company's website at:

https://investors.spirehealthcare.com/news/regulatory-news/

 

Enquiries:

 

Spire Healthcare

Harbant Samra, CFO                                                     [phone]

 

Instinctif Partners

Julian Walker                                                                 [phone]

 

Registered Office and Head Office:

 

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

 

About Spire Healthcare

 

Spire Healthcare is a leading independent healthcare group in the United Kingdom, running 38 hospitals and over 50 clinics, medical centres and consulting rooms across England, Wales and Scotland. It operates a network of private GPs and provides occupational health services to over 800 corporate clients.

 

Working in partnership with over 8,600 experienced consultants, Spire Healthcare delivered tailored, personalised care to over 1 million inpatients, outpatients and daycase patients, and occupational health programme clients, in 2023, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. It also delivers a range of private and NHS mental health, musculoskeletal and dermatological services under the Vita Health Group brand.

 

Spire Healthcare's well-located and scalable hospitals have delivered successful and award-winning outcomes, positioning the group well with patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI') providers. 98% of Spire Healthcare's inspected locations are rated 'Good', 'Outstanding' or the equivalent by health inspectors in England, Wales and Scotland.

 

Spire Healthcare is listed on the London Stock Exchange and is a member of the FTSE 250.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

POSBZLLBZFLFFBE